Evoke Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,688
| Closed | -$3.41M | – | 34 |
|
|
2026
Q1 | $3.41M | Sell |
9,688
-576
| -6% | -$205K | 0.06% | 112 |
|
|
2025
Q4 | $3.36M | Buy |
10,264
+964
| +10% | +$306K | 0.06% | 122 |
|
|
2025
Q3 | $2.62M | Buy |
9,300
+289
| +3% | +$83.8K | 0.05% | 137 |
|
|
2025
Q2 | $2.52M | Buy |
9,011
+744
| +9% | +$211K | 0.06% | 129 |
|
|
2025
Q1 | $2.58M | Buy |
8,267
+354
| +4% | +$105K | 0.07% | 115 |
|
|
2024
Q4 | $2.06M | Sell |
7,913
-233
| -3% | -$69.1K | 0.06% | 124 |
|
|
2024
Q3 | $2.62M | Buy |
+8,146
| New | +$2.66M | 0.07% | 104 |
|
|
2024
Q2 | – | Sell |
-7,997
| Closed | -$2.27M | – | 120 |
|
|
2024
Q1 | $2.27M | Buy |
+7,997
| New | +$2.34M | 0.07% | 103 |
|
|
2023
Q4 | – | Sell |
-7,904
| Closed | -$2.12M | – | 106 |
|
|
2023
Q3 | $2.12M | Buy |
7,904
+162
| +2% | +$40.4K | 0.07% | 115 |
|
|
2023
Q2 | $1.72M | Sell |
7,742
-194
| -2% | -$45K | 0.06% | 118 |
|
|
2023
Q1 | $1.92M | Sell |
7,936
-357
| -4% | -$87.6K | 0.07% | 111 |
|
|
2022
Q4 | $2.18M | Buy |
8,293
+240
| +3% | +$64.3K | 0.08% | 110 |
|
|
2022
Q3 | $1.81M | Buy |
8,053
+286
| +4% | +$69.3K | 0.07% | 104 |
|
|
2022
Q2 | $1.89M | Buy |
7,767
+207
| +3% | +$50.7K | 0.07% | 113 |
|
|
2022
Q1 | $1.83M | Sell |
7,560
-1,477
| -16% | -$339K | 0.06% | 125 |
|
|
2021
Q4 | $2.03M | Sell |
9,037
-201
| -2% | -$42.4K | 0.06% | 126 |
|
|
2021
Q3 | $1.96M | Buy |
9,238
+269
| +3% | +$61.9K | 0.07% | 122 |
|
|
2021
Q2 | $2.19M | Buy |
8,969
+25
| +0.3% | +$6.15K | 0.08% | 118 |
|
|
2021
Q1 | $2.23M | Buy |
8,944
+6,982
| +356% | +$1.67M | 0.1% | 108 |
|
|
2020
Q4 | $451K | Sell |
1,962
-54
| -3% | -$12.4K | 0.03% | 157 |
|
|
2020
Q3 | $513K | Buy |
2,016
+80
| +4% | +$19.8K | 0.04% | 131 |
|
|
2020
Q2 | $457K | Sell |
1,936
-131
| -6% | -$29.9K | 0.04% | 119 |
|
|
2020
Q1 | $419K | Sell |
2,067
-753
| -27% | -$164K | 0.06% | 110 |
|
|
2019
Q4 | $680K | Buy |
2,820
+200
| +8% | +$44.1K | 0.09% | 107 |
|
|
2019
Q3 | $507K | Buy |
+2,620
| New | +$503K | 0.06% | 146 |
|
Other funds holding AMGN
Evoke Wealth's AMGN Position: Q2 2026 in Review
Evoke Wealth sold out of Amgen (AMGN) in Q2 2026, closing a stake of 9,688 shares — an estimated $3.41M sold.
Evoke Wealth first reported a position in AMGN in Q3 2019 and held it in 25 quarters. The position peaked at $3.41M in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Evoke Wealth reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Evoke Wealth sold 9,688 Amgen shares in Q2 2026, an estimated $3.41M.
- Evoke Wealth first reported a position in Amgen in Q3 2019 and held it in 25 quarters.
- Evoke Wealth's Amgen position peaked at $3.41M in Q1 2026.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.